文献速递妇科

尺寸重要吗?使用8 mm与10-12 mm辅助穿刺孔行腹腔镜顶端盆腔器官脱垂术后阿片类药物使用情况

Does Size Matter? Opioid Use after Laparoscopy for Apical Pelvic Organ Prolapse Using an 8 mm versus 10-12 mm Accessory Port.
PubMed 文献 · J Minim Invasive Gynecol · 2021-12-17

这项前瞻性队列研究纳入92例子宫阴道穹窿顶端脱垂行腹腔镜自体组织悬吊术的女性,比较10-12 mm与8 mm侧辅助穿刺孔对术后24小时阿片类药物用量的影响。结果显示8 mm组平均吗啡当量日剂量显著低于10-12 mm组(13.6 vs 35.3,P<.001),且未使用阿片类药物及未开具阿片类药物处方的比例均更高。

要点

  • 8 mm侧辅助穿刺孔组术后24小时平均吗啡当量日剂量为13.6,低于10-12 mm组的35.3(P<.001)。
  • 8 mm组术后未使用阿片类药物的比例为45.2%(19例),高于10-12 mm组的18.0%(9例),粗比值比为3.76(95%CI 1.47-9.66)。
  • 8 mm组出院后未开具阿片类药物处方的比例为35.7%(15例),高于10-12 mm组的16.0%(8例),粗比值比为2.92(95%CI 1.09-7.81)。

核心结论

  • 与10-12 mm穿刺孔相比,腹腔镜自体组织顶端盆腔器官脱垂手术中使用8 mm侧辅助穿刺孔与术后第一个24小时阿片类药物使用减少相关。

研究设计与样本

  • 前瞻性队列研究,对象为参与盆腔器官脱垂手术登记的女性,共纳入92例。
  • 研究在加拿大卡尔加里的三级学术医院进行,研究期为2020年6月至2021年9月共15个月。
  • 研究对象为因≥2期盆腔器官脱垂行腹腔镜子宫骶韧带顶端悬吊术、保留子宫或同时行子宫切除术的女性。
  • 干预为使用10-12 mm或8 mm侧辅助穿刺孔,穿刺孔尺寸在研究期中点改变,10-12 mm穿刺孔的筋膜缺损用筋膜闭合装置关闭。

主要发现

  • 50例(54.3%)使用10-12 mm侧辅助穿刺孔,42例(45.7%)使用8 mm侧辅助穿刺孔。
  • 术后平均吗啡当量日剂量10-12 mm组为35.3(95%CI 24.9-45.6),8 mm组为13.6(95%CI 8.0-19.2),P<.001。
  • 术后未使用阿片类药物的比例8 mm组为45.2%(19例),10-12 mm组为18.0%(9例),粗比值比3.76(95%CI 1.47-9.66)。
  • 出院后未开具阿片类药物处方的比例8 mm组为35.7%(15例),10-12 mm组为16.0%(8例),粗比值比2.92(95%CI 1.09-7.81)。
  • 调整年龄、体重指数、种族和民族、手术时长及同时进行的手术操作后,结果仍具有统计学显著性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To determine whether a change in lateral accessory port (LAP) size from 10-"?>12 mm to 8 mm among women undergoing laparoscopic native tissue pelvic organ prolapse (POP) surgery was effective at reducing opioid use after surgery. DESIGN: Prospective cohort of women taking part in a POP surgical registry. SETTING: Tertiary academic hospital in Calgary, Canada. PATIENTS: Women undergoing laparoscopic uterosacral ligament apical suspensions for stage ≥2 POP with either uterine preservation or concomitant hysterectomy. A total of 92 women were included during a 15-month study period from June 2020 and September 2021. INTERVENTIONS: Laparoscopic apical suspension using either a 10-"?>12 mm or 8 mm LAP, with the change occurring at the midpoint of the study period. Fascial defects from 10-"?>12 mm ports were closed with a fascial closure device. Perioperative care and technique were otherwise unchanged. MEASUREMENTS AND MAIN RESULTS: Postoperative opioid use was measured by mean morphine equivalent daily dose, accounting for all oral and intravenous opioids used in the first 24 hours after surgery. A total of 50 cases (54.3%) used a 10-12 mm LAP, and 42 cases (45.7%) used an 8 mm LAP. Mean morphine equivalent daily dose after surgery with a 10-12 mm LAP was significantly higher than with an 8 mm LAP (35.3 [95% confidence interval (CI) 24.9-45.6] vs 13.6 [95% CI 8.0-19.2], p <.001). The proportion of women who did not require opioids postoperatively was higher in the 8 mm group (45.2%, n = 19) than the 10-12 mm group (18.0%, n = 9) (crude odds ratio 3.76, 95% CI 1.47-9.66). Similarly, the proportion of women who did not fill an opioid prescription after discharge was higher in the 8 mm group (35.7%, n = 15) than the 10-12 mm group (16.0%, n = 8) (crude odds ratio 2.92, 95% CI 1.09-7.81). These results remained statistically significant after adjustment for age, body mass index, race and ethnicity, length of procedure, and concomitant procedures performed. CONCLUSION: Compared with a 10-12 mm port, the use of an 8 mm LAP during laparoscopic native tissue apical POP surgery is associated with decreased opioid use in the first 24 hours after surgery.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Edwards A, Carter Ramirez A, Scime NV, et al. Does Size Matter? Opioid Use after Laparoscopy for Apical Pelvic Organ Prolapse Using an 8 mm versus 10-12 mm Accessory Port. J Minim Invasive Gynecol. 2021. PMID: 34929399. doi:10.1016/j.jmig.2021.12.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。